Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial
| Image |  |
|---|---|
| Description | scientific article published on 25 October 2013 |
| Author/s |
author: Nicholas J. Vogelzang Viktor Stus |
| Publication date | October 25, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |